BACKGROUND: Dominantly inherited Creutzfeldt-Jakob disease (CJD) represents 5% to 15% of all CJD cases. The E200K mutation in the prion protein (PrP) gene (PRNP) is the most frequent cause of familial CJD. Coexistent amyloid beta (Abeta) plaques have been reported in some transmissible spongiform encephalopathies but to date have not been reported in familial CJD with the E200K mutation. OBJECTIVE: To characterize a family with CJD in which Abeta plaques codistribute with spongiform degeneration. DESIGN: Clinicopathologic and molecular study of a family with CJD with the E200K-129M haplotype. SETTING: Alzheimer disease research center. PARTICIPANTS: Two generations of a family. MAIN OUTCOME MEASURES: Clinical, biochemical, and neuropathologic observations in 2 generations of a family. RESULTS: In this kindred, 3 autopsied cases showed pathologic changes typical for the E200K-129M haplotype, including spongiform degeneration, gliosis, neuronal loss, and PrP deposition. Moreover, 2 of these cases (ages 57 and 63 years) showed numerous Abeta plaques codistributed with spongiform degeneration. APOE genotyping in 2 cases revealed that Abeta plaques were present in the APOE epsilon4 carrier but not in the APOE epsilon4 noncarrier. Two additional cases exhibited incomplete penetrance, as they had no clinical evidence of CJD at death after age 80 years but had affected siblings and children. CONCLUSIONS: To our knowledge, this is the first description of Abeta plaques in familial CJD with the E200K mutation. The codistribution of plaques and CJD-associated changes suggests that PrP plays a central role in Abeta formation and that Abeta pathology and prion disease likely in fluence each other. The kindred described herein provides support that PrP(E200K) may result in increased Abeta deposition.
BACKGROUND:Dominantly inherited Creutzfeldt-Jakob disease (CJD) represents 5% to 15% of all CJD cases. The E200K mutation in the prion protein (PrP) gene (PRNP) is the most frequent cause of familial CJD. Coexistent amyloid beta (Abeta) plaques have been reported in some transmissible spongiform encephalopathies but to date have not been reported in familial CJD with the E200K mutation. OBJECTIVE: To characterize a family with CJD in which Abeta plaques codistribute with spongiform degeneration. DESIGN: Clinicopathologic and molecular study of a family with CJD with the E200K-129M haplotype. SETTING:Alzheimer disease research center. PARTICIPANTS: Two generations of a family. MAIN OUTCOME MEASURES: Clinical, biochemical, and neuropathologic observations in 2 generations of a family. RESULTS: In this kindred, 3 autopsied cases showed pathologic changes typical for the E200K-129M haplotype, including spongiform degeneration, gliosis, neuronal loss, and PrP deposition. Moreover, 2 of these cases (ages 57 and 63 years) showed numerous Abeta plaques codistributed with spongiform degeneration. APOE genotyping in 2 cases revealed that Abeta plaques were present in the APOE epsilon4 carrier but not in the APOE epsilon4 noncarrier. Two additional cases exhibited incomplete penetrance, as they had no clinical evidence of CJD at death after age 80 years but had affected siblings and children. CONCLUSIONS: To our knowledge, this is the first description of Abeta plaques in familial CJD with the E200K mutation. The codistribution of plaques and CJD-associated changes suggests that PrP plays a central role in Abeta formation and that Abeta pathology and prion disease likely in fluence each other. The kindred described herein provides support that PrP(E200K) may result in increased Abeta deposition.
Authors: G G Kovács; L László; A Bakos; J Minárovits; M T Bishop; T Ströbel; B Vajna; E Mitrova; K Majtényi Journal: Neurology Date: 2005-11-22 Impact factor: 9.910
Authors: P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti Journal: Ann Neurol Date: 1996-06 Impact factor: 10.422
Authors: Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova Journal: Hum Genet Date: 2005-11-15 Impact factor: 4.132
Authors: H S Lee; N Sambuughin; L Cervenakova; J Chapman; M Pocchiari; S Litvak; H Y Qi; H Budka; T del Ser; H Furukawa; P Brown; D C Gajdusek; J C Long; A D Korczyn; L G Goldfarb Journal: Am J Hum Genet Date: 1999-04 Impact factor: 11.025
Authors: P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar Journal: Ann Neurol Date: 1999-08 Impact factor: 10.422
Authors: R B Petersen; M Tabaton; S G Chen; L Monari; S L Richardson; T Lynch; V Manetto; D J Lanska; W R Markesbery; T ] Lynches T [corrected to Lynch Journal: Neurology Date: 1995-06 Impact factor: 9.910
Authors: Walker S Jackson; Andrew W Borkowski; Nicki E Watson; Oliver D King; Henryk Faas; Alan Jasanoff; Susan Lindquist Journal: Proc Natl Acad Sci U S A Date: 2013-08-19 Impact factor: 11.205
Authors: Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero Journal: J Neurol Date: 2012-07-05 Impact factor: 4.849
Authors: Gabor G Kovacs; Mirjam I Lutz; Gerda Ricken; Thomas Ströbel; Romana Höftberger; Matthias Preusser; Günther Regelsberger; Selma Hönigschnabl; Angelika Reiner; Peter Fischer; Herbert Budka; Johannes A Hainfellner Journal: Acta Neuropathol Date: 2016-03-25 Impact factor: 17.088